INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 16 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 815,789 | $3,541,000 | 1.78% |
| MEITAV INVESTMENT HOUSE LTD | 2,460,136 | $10,651,000 | 0.71% |
| DAFNA Capital Management LLC | 415,989 | $1,805,000 | 0.68% |
| KNOTT DAVID M | 259,377 | $1,126,000 | 0.48% |
| SECTORAL ASSET MANAGEMENT INC | 879,000 | $3,815,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 620,000 | $2,691,000 | 0.37% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 283,434 | $1,230,000 | 0.17% |
| Harel Insurance Investments & Financial Services Ltd. | 624,809 | $2,711,000 | 0.14% |
| Avoro Capital Advisors LLC | 820,000 | $3,559,000 | 0.12% |
| MENTA CAPITAL LLC | 52,792 | $229,000 | 0.10% |